Yu Shen

20PUBLICATIONS
68CO-AUTHORS
Midwifery not elsewhere classifiedPredictive and prognostic markersStochastic analysis and modellingCancer therapy (excl. chemotherapy and radiation therapy)European history (excl. British, classical Greek and Roman)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 28, 2026
Prevalence and Outcomes of HER2-Low Versus HER2-0 Status in Patients with Metastatic Breast Cancer.

Akshara Singareeka Raghavendra, Diane D Liu, Senthil Damodaran

|Oct 18, 2025
Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer.

Takeo Fujii, Toshiaki Iwase, Yu Shen

|May 26, 2025
Conformal predictive intervals in survival analysis: a resampling approach.

Jing Qin, Jin Piao, Jing Ning

|Feb 22, 2025
Sequence of therapy impact on older women with comorbidities and triple-negative or HER2-positive breast cancer.

Nina Tamirisa, Wenli Dong, Yu Shen

|Jan 26, 2025
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.

Akshara Singareeka Raghavendra, Nicole M Kettner, Danielle Kwiatkowski

|Oct 29, 2024
Likelihood adaptively incorporated external aggregate information with uncertainty for survival data.

Ziqi Chen, Yu Shen, Jing Qin

Pageof 4

Frequent Collaborators

5 joint publications

Naoto T Ueno

4 joint publications

Debu Tripathy

3 joint publications

Isabelle Bedrosian

3 joint publications

Jing Ning